Markets are down today as inflation concerns persist. The post Stock Market Today: Dow Jones, S&P 500 Ease Lower; Roku Stock Surges After Report Of...
Stock index futures lose steam as Target warns investors of short-term profit growth headwinds. The post Top Stock Market News For Today June 8, 2022 appeared...
Powered by its blockbuster checkpoint inhibitor Keytruda, Merck is forecasting the potential of more than 80 new regulatory approvals in oncology through...
Pfizer Inc. (NYSE: PFE) is continuing to make efforts toward protecting young children from COVID-19 infection. The company has recently announced that...
In this week’s Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview Biomedical Engineer and Revive Therapeutics...
The outlook for Revive Therapeutics Ltd. (CNSX: RVV, OTCMKTS: RVVTF) Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat...
CytoDyn Inc (OTCMKTS: CYDY) continues to move steadily higher in recent trading since hitting lows of $0.231 after the FDA placed a partial clinical hold...
There appears to be a rise in COVID-19 illnesses, driven by Omicron subvariants, which may be better able to evade immunity from vaccines and previous...
With increasing concerns about COVID-19 reinfection, Pfizer and the National Institutes of Health are discussing potential studies regarding a longer treatment...
It’s been a long and arduous road for Revive Therapeutics Ltd. (CNSX: RVV, OTCMKTS: RVVTF) regarding their Phase 3 clinical trial to evaluate the...
On May 17, the U.S. FDA authorized a booster of Pfizer's vaccine for kids ages 5 to 11 years. The action comes as major cities are announcing...
COVID-19 would have claimed over 110,000 more lives in 2021 if not for the Pfizer-BioNTech vaccine, according to a Pfizer-sponsored report on the first...
The U.S. Food and Drug Administration decided not to authorize the antidepressant fluvoxamine to treat COVID-19, saying the data has not shown the drug...
With the relaxation of mask-wearing mandates, there’s even more need to know how much over-the-counter tests help.
Eli Lilly scored another win against diabetes Friday as the company’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like...
Moderna Inc. has made all necessary submissions required by the U.S. Food and Drug Administration for emergency use authorization of the company's COVID-19...
The U.S. Food and Drug Administration (FDA) has given approval for the commercialization of Eli Lilly and Company and Incyte’s Olumiant (baricitinib),...
About four weeks before FDA’s outside advisors are slated to review Novavax’s Covid-19 jab after a long, federally-funded and winding journey that...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
Could these health care stocks be the remedy to investors’ recent stock market pains? The post Best Stocks To Buy Now? 5 Health Care Stocks In...
The Janssen COVID-19 vaccine is now limited to certain individuals ages 18 and up after the U.S. Food and Drug Administration downgraded its emergency...
The U.S. Food and Drug Administration indirectly refuted Pfizer's recommendation that it's all right for COVID-19 patients to take another round of Paxlovid...
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development...
'Deep State' Was Working Against Trump On COVID-19 Response: Dr. Paul Alexander Authored by Harry Lee and Roman Balmakov via The Epoch Times, According...
Moderna Inc.'s chief medical officer said on Sunday the company's vaccine for children under 6 years old will be ready for review by a Food and...
Stock index futures gain ground going into key economic policy updates from the central bank. The post Top Stock Market News For Today May 2, 2022...
Children ages 6 months to under 6 years may soon have access to a Covid-19 vaccine that has been submitted to the FDA for emergency use...
An infections disease doctor discusses the use, benefits and availability of a drug to prevent severe COVID-19.
Revive Therapeutics has provided an update on Phase 3 of its Bucillamine clinical trial. Bucillamine is a drug developed to treat coronavirus. There...
Media’s Collusion With Executive Branch Destroyed Trust In Public Health: Dr. Ben Carson Authored by Masooma Haq and Roman Balmakov via...